| Net Cash Provided by (Used in) Operating Activities |
$15,775,000 |
USD |
68% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$70,815,000 |
USD |
172% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,467,000 |
USD |
45% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
700,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
133,200,000 |
shares |
11% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$55,287,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$73,456,000 |
USD |
-16% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$139,953,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$140,527,000 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$672,000 |
USD |
93% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$55,657,000 |
USD |
71% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$938,000 |
USD |
9.6% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$73,205,000 |
USD |
23% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$622,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$574,000 |
USD |
31% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$12,598,000 |
USD |
-22% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$1,657,000 |
USD |
-8.8% |
Q1 2025 |
Q1 2025 |